These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9574863)

  • 1. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C; Stein DJ
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.
    Atmaca M; Kuloglu M; Tezcan E; Unal A
    Hum Psychopharmacol; 2002 Dec; 17(8):401-5. PubMed ID: 12457375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania.
    Stein DJ; Bouwer C; Maud CM
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(4):234-6. PubMed ID: 9332906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label trial of escitalopram in children and adolescents with social anxiety disorder.
    Isolan L; Pheula G; Salum GA; Oswald S; Rohde LA; Manfro GG
    J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):751-60. PubMed ID: 18315447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram in social phobia.
    Kosieradzki PH
    J Am Acad Child Adolesc Psychiatry; 2001 Oct; 40(10):1126-7. PubMed ID: 11589525
    [No Abstract]   [Full Text] [Related]  

  • 8. An open trial of topiramate in the treatment of generalized social phobia.
    Van Ameringen M; Mancini C; Pipe B; Oakman J; Bennett M
    J Clin Psychiatry; 2004 Dec; 65(12):1674-8. PubMed ID: 15641873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram for social phobia: a clinical case series.
    Simon NM; Sharma SG; Worthington JJ; Marzol PC; Pollack MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1469-74. PubMed ID: 11513360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of social anxiety disorder with citalopram.
    Varia IM; Cloutier CA; Doraiswamy PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):205-8. PubMed ID: 11853114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.
    Stein MB; Liebowitz MR; Lydiard RB; Pitts CD; Bushnell W; Gergel I
    JAMA; 1998 Aug; 280(8):708-13. PubMed ID: 9728642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.
    Furmark T; Appel L; Michelgård A; Wahlstedt K; Ahs F; Zancan S; Jacobsson E; Flyckt K; Grohp M; Bergström M; Pich EM; Nilsson LG; Bani M; Långström B; Fredrikson M
    Biol Psychiatry; 2005 Jul; 58(2):132-42. PubMed ID: 16038684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
    Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
    J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP
    J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.
    Stein DJ; Berk M; Els C; Emsley RA; Gittelson L; Wilson D; Oakes R; Hunter B
    S Afr Med J; 1999 Apr; 89(4):402-6. PubMed ID: 10341825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
    Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP
    Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram in the treatment of early-onset panic disorder and school phobia.
    Lepola U; Leinonen E; Koponen H
    Pharmacopsychiatry; 1996 Jan; 29(1):30-2. PubMed ID: 8852532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram treatment of social anxiety disorder with comorbid major depression.
    Schneier FR; Blanco C; Campeas R; Lewis-Fernandez R; Lin SH; Marshall R; Schmidt AB; Sanchez-Lacay JA; Simpson HB; Liebowitz MR
    Depress Anxiety; 2003; 17(4):191-6. PubMed ID: 12820174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of relapse in generalized social phobia: results of a 24-week study in responders to 20 weeks of sertraline treatment.
    Walker JR; Van Ameringen MA; Swinson R; Bowen RC; Chokka PR; Goldner E; Johnston DC; Lavallie YJ; Nandy S; Pecknold JC; Hadrava V; Lane RM
    J Clin Psychopharmacol; 2000 Dec; 20(6):636-44. PubMed ID: 11106135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.